Is Recurrence After Treatment Predictable? Risk Factors in Dupuytren Disease




© Springer International Publishing Switzerland 2017
Paul M. N. Werker, Joseph Dias, Charles Eaton, Bert Reichert and Wolfgang Wach (eds.)Dupuytren Disease and Related Diseases – The Cutting Edge10.1007/978-3-319-32199-8_39


39. Is Recurrence After Treatment Predictable? Risk Factors in Dupuytren Disease



Maarten Van Nuffel  and Ilse Degreef 


(1)
Hand Unit, Department of Orthopedics, University Hospitals Leuven, Weligerveld 1, 3212 Pellenberg, Belgium

 



 

Maarten Van Nuffel (Corresponding author)



 

Ilse Degreef




Keywords
Dupuytren diseaseRisk factorsFibrosis diathesisRecurrenceContracture



39.1 Introduction


Dupuytren Disease (DD) is a connective tissue disorder characterized as nodular palmar fibromatosis, which causes permanent contraction of one or more fingers. In general, these nodules and contractures are not painful but can lead to severe functional impairment. Despite huge amounts of research on the clinical, histopathological and molecular aspects of DD, many aspects of this condition remain unclear.


39.2 Background



39.2.1 Recurrence


When discussing the predictability of recurrence, one needs a clear definition of recurrence. A distinction needs to be made between an objective recurrence of contracture, as measured by a clinician, and a subjective recurrence, as perceived by the patient. Historically, the objective definition of recurrence was mainly based on disease recurrence in a previously operated field (Hueston 1963a; Gordon 1957; Leclercq 2000). Defining recurrence in different ways has caused a lot of confusion in the literature and makes comparing studies difficult. This also explains the wide range of recurrence rates from 2 to 86 % (Becker and Davis 2010; Kan et al. 2013; Werker et al. 2012). To overcome this problem, an international consensus has been published in 2014 (Felici et al. 2014). Using the Delphi method, an international committee of hand surgeons defined recurrence as a passive extension deficit (PED) of more than 20° for at least one treated joint, in the presence of a palpable cord, compared to the result obtained at time 0. Time 0 was defined as the period between 6 weeks and 3 months after treatment and is the time when treatment results can be considered stable. Recurrence needs to be distinguished from extension, which is considered the development of nodules or cords in adjacent fingers or other areas not operated before (Tonkin et al. 1984).


39.2.2 Disability


On the other hand, patients often desire treatment based on their functional impairment, and this is not always correlated to the objective degree of contracture. Professional activities and hobbies may influence the degree to which patients are impaired by the disease and the moment they request treatment of the contractures. In 2009, Degreef et al. (2009a) reported that there seems to be no correlation between the degree of contracture and the disability, as expressed by the DASH score (disability of arm, shoulder and hand). One of the problems is that the DASH score is not specific enough for DD. In 2013 Wilburn et al. demonstrated that DD affects both performance of activities and quality of life, and they expressed the need for DD-specific outcome scales that are valid, reproducible and responsive. In the same year, Ball et al. (2013) published a systematic review on functional outcome measures in DD. They recommended the use of a region-specific questionnaire such as the Michigan Hand Questionnaire (MHQ) and a validated disease-specific patient-related outcome measure like the Unité Rhumatologique des Affections de la Main (URAM) scale (Beaudreuil et al. 2011). They also mentioned that adding the designation of tasks important to each patient would be useful, as well as indicating the degree of difficulty before and after treatment on a linear scale. Lastly, patient’s satisfaction should be assessed using a valid and reliable questionnaire or patient evaluation measure.


39.2.3 Rationale


In the past decades, several authors have been searching for the factors that are associated with a high recurrence rate after surgery. For example, if the recurrence risk could be predicted based on these findings, patients with a high recurrence risk would be more frequently splinted and checked after the operation. This is particularly interesting since there is an increasing debate on the usefulness of splinting postoperatively (Collis et al. 2013; Larson and Jerosch-Herold 2008; Jerosch-Herold et al. 2011). Interestingly, in hand rehabilitation after tendon repair, hand therapists seem to classify their patients during the rehabilitation as “scar formers” or “non-scar formers” and may adapt the rehabilitation protocol according to this classification (Pitbladdo and Strauss-Schroeder 2013). If the same could be done in the postoperative period after treatment for DD, recurrence rates after treatment might improve significantly, independent of the type of initial treatment.


39.3 Surgical Factors


There is still a lot of debate about the best surgical procedure for finger contractures in DD, and most techniques have both enthusiastic supporters and opponents. The same is true for less invasive treatment methods such as percutaneous needle aponeurotomy and collagenase injections.

For example, our group published the results of 3 different operations for DD with contracture of the proximal interphalangeal (PIP) joint. Sixteen patients underwent an open fasciectomy, 13 patients underwent a segmental fasciectomy as described by Moermans (Moermans 1991) and 9 underwent a dermofasciectomy with full-thickness graft. At a mean follow-up of 54 months (range 27–75), the type of operation was not related to the recurrence rate. However, the preoperative extension deficit in the PIP joint was significantly correlated with recurrence (van Giffen et al. 2006). Misra et al. published their results in 2007 and demonstrated that the need for joint release was not correlated with recurrence in 49 PIP joints in 37 patients. Again, the severity of the preoperative contracture (more than 60°) and incomplete correction of the PIP joint contracture were associated with the recurrence at 18 months (Misra et al. 2007). Degreef et al. reported in 2009 on the self-reported recurrence rates in 216 surgically treated patients with a minimal follow-up of 2 years. Surprisingly, the recurrence rate in the four different operative techniques (Z-plasty, Bruner incision, segmental fasciectomy or dermofasciectomy with full-thickness graft) was not significantly different. Moreover, the recurrence rate in the dermofasciectomy with full-thickness graft as a revision procedure was higher than when this was done as a primary procedure (Degreef et al. 2009c). Roush and Stern published similar findings in 2000; they demonstrated that the total active motion (TAM) after dermofasciectomy with full-thickness graft for recurrent DD was no longer different from the preoperative TAM at a 4-year follow-up examination. However, fasciectomy with local flap coverage seemed to be the only technique that still had an improved TAM at the 4-year follow-up (Roush and Stern 2000).

As mentioned before, the self-reported recurrence rate, although a very subjective parameter, cannot be ignored in the evaluation of treatment of DD. Dias and Braybrooke also reported on the self-reported recurrence in an audit in 1177 patients in 2006. A multi-centre postal questionnaire study was conducted by the Audit Committee of the British Society for Surgery of the Hand. With a mean follow-up of 27 months, they found that recurrence was more common in patients with greater initial deformity and less common if adequate correction was achieved at the time of surgery (Dias and Braybrooke 2006). It appears that the immediate postoperative result is more important in preventing recurrence than the surgical technique used to achieve the correction.

The potential benefit of a full-thickness graft remains a subject of debate. In the 1984 study by Tonkin et al., they found an overall recurrence rate of 46.5 % in 229 operations with a mean follow-up of 37.7 months (range 9–90). The recurrence rate was the highest in men who were treated with fasciectomy alone (54 %), although the combination with full-thickness grafting still showed significant recurrence rates, both as a primary procedure (33 %) and as a revision procedure (42 %) (Tonkin et al. 1984). Ullah et al. reported their results in 2009; in 90 fingers, 44 underwent a dermofasciectomy with a so-called “firebreak” skin graft and 46 underwent a fasciectomy. With a mean follow-up of 36 months, they found an overall recurrence rate of 12.2 %, but there was no difference in recurrence rate between the two groups (Ullah et al. 2009). Interestingly, the same patient cohort was reviewed 2 years later, 63 of these patients could be included and there appeared to be 4 types of evolution after the operation, independent of the initial surgery. They differentiated between minimal re-contracture, mild early recurrence, severe early recurrence and progressive re-contracture. Worsening of the contracture more than 6° between 3 and 6 months after surgery seemed to predict a progressive re-contracture at 5 years (Dias et al. 2013).


39.4 Genetics


It appears that there are inherent, patient-related factors that influence the outcome after surgery. It is well known that DD can have a strong familial predisposition, and a lot of research has been done to identify the genes involved (Bayat et al. 2002; Bayat et al. 2003; Hindocha et al. 2006a; Hu et al. 2005). For example, Dolmans et al. reported in 2012 that there were 9 single nucleotide polymorphisms (SNPs) associated with DD in a genome-wide association study. DD patients with clinical diathesis features (predominantly knuckle pads) are more likely to carry more risk alleles for the discovered DD SNPs than patients without these diathesis features (Dolmans et al. 2012).

A detailed description of the genetic factors in DD falls outside of the scope of this chapter. However, the knowledge of these genetic factors might give us more insight in predicting recurrence, especially since the expression patterns of these genes can be evaluated on histological examination.


39.5 Histopathology


The idea of using histopathology to identify patients at risk for recurrence is not new, but it is still unclear if the underlying process is an inflammatory process or a neoplasm (Wang and Zhu 2006). This makes the development of histological classification more troublesome. Already in 1959, Luck described different histological stages of DD, namely, “cell-rich” proliferation and involution stages versus residual “cell-poor” stages. The latter is supposed to be correlated with a less-active disease (Luck 1959). Rombouts et al. also examined a correlation between histological classification and recurrence. They described 3 types of histology obtained during fasciectomy in 77 hands of 63 patients. The proliferative type had a high cellularity and mitosis rate, and the fibrocellular type showed a prominent reticulin network, whereas the third or fibrous type contained only few cells. The recurrence rate in patients with type 1 was 70 % versus 18 % in type 3 patients at a mean follow-up of 5 years (range 2–10) (Rombouts et al. 1989).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 4, 2017 | Posted by in ORTHOPEDIC | Comments Off on Is Recurrence After Treatment Predictable? Risk Factors in Dupuytren Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access